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Abstract
Background:   CMV infections have been linked to vasculopathies like atherosclerosis and
Scleroderma. CMV infects vascular endothelium with intermittent shedding of the virus and the
development of latency.
Methods:  We adopted a model of arteritis, developed by Presti et al. (1998), triggered by murine
cytomegalovirus (MCMV) infection. Our studies focused on neointima formation. Groups of mice
include: 1) immunocompetent 129S, 2) immunocompetent 129S receiving whole body irradiation
and MCMV, 3) IFN-γ R-/- receiving MCMV, and 4) IFN-γ R-/- receiving MCMV and whole body
irradiation.
Results:  Mice were inoculated with MCMV (5 x 104 or 1 x 105 PFU's) by i.p. injection; hearts and
abdominal aortas were collected and histopathology evaluated. Infected immunocompetent animals
exhibited widespread perivascular inflammation, which subsided by 8 weeks. Intimal pathology was
not observed in any control group. Immunocompetent animals receiving MCMV and irradiation
developed mild to moderate intimal lesions associated with medial and adventitial inflammation.
IFN-γ R-/- mice infected for 4 months and receiving whole body irradiation 2 months after infection
developed pathology characterized by extensive adventitial and medial infiltrate and significant
neointima, suggesting that infection and immunosuppression were co-requisites of neointima
formation. Immunohistochemical analysis revealed myofibroblasts as a major component of
neointima. The disease is characterized by up-regulation of growth factors (TGF-β 1, PDGF-A and
B). Apoptosis was detected in the intimal layer of affected aortas. Active proliferation of
myofibroblasts and infiltrating cells was also detected.
Conclusion:  These results indicate that CMV infections may lead to intimal injury that results in
the formation of neointima characteristic of autoimmune vasculopathies.
Editorial note
A commentary on this article can be found at  [http://
www.biomedcentral.com/1471-8219/2/5] 
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Introduction
Cardiovascular diseases, a major health concern in in-
dustrialized countries [1–4], include vasculopathies such
as atherosclerosis [5] and autoimmune vascular diseases
such as lupus [6], graft versus host disease [7], and sys-
temic sclerosis [8]. Many factors are involved in the de-
velopment and progression of these diseases including
lifestyle (diet, smoking, and lack of physical exercise);
genes, and environment [1–4]. Also, infectious agents,
including both bacterial (Chlamydia) [9,10], and viral
(CMV) [11,12], have been implicated. CMV, a herpes vi-
rus, causes chronic asymptomatic infections in immuno-
competent individuals, termed latency [13]. However, in
situations of immunocompromise, CMV is reactivated,
which in many cases leads to organ failure and death
[13]. Epidemiological reports indicate that chronic CMV
infections in humans may play an important role in
pathogenesis of vascular diseases such as atherosclerosis
[14] and systemic sclerosis [11,12]. In addition, a recent
report [15] revealed that SSc autoantibodies bind to CMV
late protein UL94 and induce apoptosis in endothelial
cells therefore implicating molecular mimicry as a po-
tential mechanism accounting for the link between SSc
and CMV.
Here we report that MCMV infections of gene-targeted
mice lacking IFN-γ R and subjected to whole body irradi-
ation develop vascular lesions that over 4 months
progress to severe vasculopathy characterized by signifi-
cant neointima formation, a prominent feature of au-
toimmune vasculopathies in humans. Furthermore,
imunohistochemical analyses indicate the presence of
significant lymphohistiocytic infiltrate in the adventitia
of affected arteries containing both T and B-lym-
phocytes. Neointima stained positive for both -smooth
muscle actin and PCNA indicating proliferation of
smooth muscle cells possibly mediated by growth factors
TGF-β 1, PDGF-A and PDGF-B, while TUNEL indicated
apoptosis in the intimal layer in affected arteries.
Materials and methods
Mice
All experiments described in this study confirm with
"The guide for the Care and Use of Laboratory Animals"
published by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1996). CD-1 mice used for
generating the MCMV stock were purchased from
Charles River Laboratories (Wilmington, MA). Experi-
mental groups included: 1) adult, immunocompetent
129S mice, and 2) adult B6,129S IFN-γ R-/- mice, both
obtained from Jackson Laboratories (Bar Harbor, MN).
Food and water were provided ad libitum. All mice were
housed in hepa filtered cages in the approved animal fa-
cility and monitored daily for the development of clinical
manifestations of infection.
Preparation of MCMV stock and infection protocol
MCMV strain Smith stock was purchased from American
Type Tissue Collection (Rockville, MD) This virus stock
had been propagated in SC-1 cells (mouse embryo fi-
broblast cell line). To enhance pathogenicity, the virus
was passed three times in adult immunocompetent CD-1
mice, which were infected with MCMV by i.p. injection
with 5 x 105 plaque forming units (pfu). Two weeks after
infection mice were sacrificed, salivary glands were col-
lected, and virus stock was prepared as a 10% weight/
volume homogenate. Concentration of virus in these ho-
mogenates was determined by a standard plaque assay
on an infected 3T-12 fibroblast cell line. Final MCMV
stock contained 4.2 x 106 PFUs/ml of salivary gland ho-
Table 1: Overview of the time course and incidence of vascular 
pathology in IFN-γ R-/- mice
Age (months)
Experimental group 2.5 3.0 3.5 4.0* 4.5 6.0
IFN-γ R-/-MCMV+IRR - - - - 6/6 8/8
IFN-γ R-/- MCMV 0/6 2/6 4/6 4/8 4/6 5/8
Controls ¶ - 0/6 - 0/8 - 0/4
Mice were infected at the age of 2 months. * = Irradiation. Results are 
presented as number of animals affected / total number of animals in 
the group. ¶ = 129S, immunocompetent mice infected with MCMV.
Table 2: Overview of experimental groups of mice and seveverity 
of vascular disease.
Lesions*
Genetic MCMV Intima Media Adventitia
IFN-γ R-/- + Genetic ++++ ++++
IFN-γ R-/- + - ++ ++ ++
W i l d  t y p e +++ + +
Wild type + - 0 0 0
Controls¶ -- / +0 0 0
MCMV = MCMV infection 4 months, IRR = whole body irradiation * = 
0 – 4 + semi quantitative visual estimate. + = mild adventitial mononu-
clear cell infiltrate, no changes in the media or intima. ++ = significant 
adventitial inflammation also extending to the media, mild intimal thick-
ening, +++ = in addition to adventitial and medial inflammation forma-
tion of neointima. ++++ = severe obliteration due to neointima 
formation in abdominal aorta, severe inflammation of adventitia and 
media characterized by breaks in the elastica. ¶ = wild type or IFN-γ R-
/- 129S mice receiving salivary gland homogenate from uninfected ani-
mals, + IRR in half.BMC Musculoskeletal Disorders (2001) 2:3 http://www.biomedcentral.com/1471-2474/2/3
mogenate. Control animals were infected with the same
concentration of salivary gland homogenate obtained
from control uninfected CD-1 mice.
Experimental protocol
Two months old mice were injected i.p. with either
MCMV or control salivary gland homogenate. Starting at
day 15 after infection and for as long as 6 months of age,
mice were sacrificed on a biweekly basis by i.p. injection
of sodium nembutal. Hearts and abdominal aortas were
collected and histopathological and immunohistochemi-
cal analyses were performed. To both accelerate the de-
velopment of vascular pathology and to deepen the
immunocompromised state, these mice were irradiated
with a sublethal dose of gamma radiation (300 Rads) at
4 months of age. Tissue sections were coded and scoring
was performed in a blinded fashion.
Histology
H&E, Movat trichrome, and Verhoeff van Gieson, stain-
ing was performed on 4 µm sections of aortas fixed for 16
hours in neutral buffered formalin (10%), and embedded
in paraffin.
Antibodies
Polyclonal antibodies specific for CD4, CD8, γ /δ -TCR,
TGF-β 1, PDGF-A, PDGF-B, MCP-1 and polyclonal anti-
body to PCNA were purchased from Santa Cruz Biotech-
nology Inc., (Santa Cruz, CA). Polyclonal antibody to B-
lymphocyte marker (B-220) was purchased from Caltag
Laboratories (Burlingame, CA). Monoclonal antibody
specific for α -smooth muscle actin (clone 1A4) was pur-
chased from Sigma (St. Louis, MO).
Immunohistochemical analysis
Tissues were collected, fixed in formalin, and embedded
in paraffin. After deparaffinizing and two 5-minute
washes in PBS, the sections were blocked for 20 minutes
with a solution of 2% unconjugated goat anti-mouse IgG
in 1 x PBS. Indicated dilutions of the primary antibodies
were added to the slides and incubated for 2 hours at
room temperature followed by two 5-minute washes
with PBS. Biotinylated secondary IgG diluted 1:100 was
added to the slides and incubated for 30 minutes. After
two additional 5-minute PBS washes, the tissue sections
were treated with a 3% solution of hydrogen peroxide to
quench endogenous peroxidase activity. After two addi-
tional 5-minute washes, the slides were incubated for 30
minutes in the solution containing the avidin-biotin-per-
oxidase complex. Diaminobenzidine/H2O2 substrate
was allowed to react with the peroxidase labeled tissue
sections for 20 minutes. After two 1-minute rinses in dis-
tilled water, the tissue sections were counterstained with
hematoxilin, cleared and dehydrated by successive gra-
dations through 70%, 95%, and 100% ethanol followed
by a final passage in xylene. The slides were mounted and
analyzed by bright field microscopy.
Tunel
Animals were sacrificed and tissues collected and proc-
essed as described for immunohistochemistry. TUNEL
assay was performed utilizing a kit for in situ detection of
apoptosis, Oncogene, (Cambridge, MA), according to
manufacturer's instructions. Briefly, 5 µm sequential
sections were deparaffinized and fixed with 4% parafor-
maldehyde for 20 minutes at room temperature followed
by 30 minute wash in PBS. After a 5 minute rinse with
PBS, 50 µl of TUNEL reaction mixture was added to tis-
sue sections and incubated in humidified chamber for 60
minutes at 37°C followed by three 5 minute rinses in PBS
and directly analyzed under the microscope.
Results
Neointima formation triggered by MCMV infection
Both immunocompetent 129S and immunodeficient
IFN-γ R-/- mice were infected by i.p. injection at age 2
months with either 1 x 105 or 5 x 104 pfus of MCMV stock.
At 1 x 105 pfus/mouse, 90% of IFN-γ R-/- mice died with
necrotizing hepatitis between days 5-10. Reducing the
dose of MCMV to 5 x 104 pfu resulted in lower mortality
rates (30%). In the immunocompetent group no deaths
occurred at either dose of MCMV. Surviving mice that re-
ceived either dose of virus developed perivascular mono-
nuclear cellular infiltrates in a number of organs
including lungs, kidneys, and salivary glands. Vascular
disease in the IFN-γ R-/- group of mice began with devel-
opment of an inflammatory infiltrate in the adventitia of
aortas 3-4 weeks after infection in 30% of animals (Table
1) (Fig. 1A). This infiltrate was comprised predominantly
of lymphohistiocytic cells (Fig. 1A). The vascular disease
progressed over a time course of 4 months and affected
between 50 and 65 % of animals (Table 1). In the group
of IFN-γ R-/- mice receiving sublethal (300 Rads) whole
body irradiation 2 months after infection all examined
animals exhibited vascular pathology (Table 1). Animals
appeared healthy and all survived whole body irradia-
tion. In the immunocompetent group of animals these
infiltrates were cleared by 8 weeks after infection and
from that point these animals were histologically indis-
tinguishable from the uninfected group. On the contrary,
in the IFN-γ R-/- mice infected with MCMV, vascular dis-
ease progressed to the formation of neointima in aortas
by 4 months of age, (Fig. 1B,C,D). Verhoeff-van Gieson
staining indicated the focal destruction of aortic elastic
fibrils in addition to intimal thickening (Fig. 1D) Con-
trols in experiments using IFN-γ R-/- mice included: 1)
uninfected animals, 2) mice that were exposed only to
the whole body irradiation and 3) mice that received only
MCMV. Histopathological analysis of abdominal aortas
collected from transgenic, infected and irradiated ani-BMC Musculoskeletal Disorders (2001) 2:3 http://www.biomedcentral.com/1471-2474/2/3
mals revealed severe vasculitis characterized by signifi-
cant inflammatory infiltrate in the adventitia and media
(Table 2), (Fig. 2). At the same time hearts showed no
signs of disease (data not shown). Verhoeff-van Gieson
(Fig. 2C) and Movat pentachrome (Fig. 2D) staining in-
dicated the focal destruction of elastic tissue, as well as
potential trafficking of the infiltrating cells through these
breaks in the elastica. The extent of vascular damage in
all mice from this group was similar. The most striking
feature of the MCMV induced vascular disease was the
formation of neointima in aortas of MCMV infected im-
munodeficient mice after irradiation (Table 2), (Fig 2).
At the same time there was no vascular pathology in any
of the control groups (Table 2) (Fig 2A). Verhoeff-van
Gieson staining of aortas collected from IFN-γ R-/- mice
30 days after irradiation (not shown) and IFN-γ R-/-
mice 60 days after irradiation (Fig. 2) indicated that the
intimal vascular lesion induced by MCMV infection was
characterized by collagen deposition and smooth muscle
proliferation. We utilized monoclonal antibody specific
for α -SMA, a marker for myofibroblast cells, and found
that neointima seen in the aortas of MCMV infected ex-
perimental animals contained myofibroblasts. (Fig. 3).
Figure 1
Beginning of arterial wall thickening induced by infecting IFN-γ R-/- mice with MCMV.   A. H&E staining of small aortic branch
21 days after MCMV infection showing focal lymphohistiocytic adventitial infiltrate. B and C. Beginning of intimal thickening 2
months after MCMV infection (H&E staining) Spaces between black arrows indicates intimal thickening. D. Verhoeff-van Gie-
son staining showing small breaks in the elastic tissue of aorta 2 months after MCMV infection. White arrows indicate focal
adventitial inflammation and fibrosis, black arrow indicates intimal thickening, yellow arrow points to small breaks in the elastic
tissue. Objective magnification x 20
A
C
B
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Immunohistochemical characterization of immune re-
sponse to MCMV infection
Immunohistochemical characterization of the inflam-
matory infiltrate seen in the adventitia and media of the
affected aortas revealed both helper T-lymphocytes
(CD4+) (Fig. 4B) and cytotoxic T-lymphocytes (CD8+)
(Fig. 4C) throughout the lesion. Since one of the charac-
teristics of autoimmune vasculopathies is the appear-
ance of high numbers of γ /δ -TCR [16] bearing cells, we
studied this cell type in our model of vascular disease.
Results from these experiments revealed a large number
of γ /δ -TCR bearing lymphocytes throughout the lesion
(Fig. 4D). We also investigated the presence of B-lym-
phocytes in the vascular lesion of MCMV infected mice.
While T-lymphocytes were identified throughout the le-
sion these cells were mostly found in small follicles (Fig.
4A).
Figure 2
Neointima formation in the aortas of MCMV infected IFN-γ R-/- mice 2 months after whole body irradiation.
A. H&E staining of abdominal aorta collected from uninfected IFN-γ R-/- mouse 2 months after whole body irradiation. Arrow
points to the intima. B. H&E staining of a large abdominal vessel collected from MCMV infected IFN-γ R-/- mouse 4 months
after infection and 2 months after whole body irradiation. Space between arrows indicates the thickness of the neointima C.
Verhoeff-van Gieson stain of a large abdominal vessel collected from MCMV infected IFN-γ R-/- mouse 4 months after infection
and 2 months after whole body irradiation. Verhoeff-van Gieson stain: muscle (brown-yellow), collagen (red), cell cytoplasm
(yellow), nuclei (blue-black). Focal transmural necrotizing vasculitis is seen. . Space between black arrows indicate intimal thick-
ening and white arrows indicate focal adventitial inflammation and fibrosis. D. Movat staining of a large abdominal vessel col-
lected from MCMV infected IFN-γ  R-/- mouse 4 months after infection and 2 months after whole body irradiation. Movat stain:
elastica (black), collagen and reticular fibers (yellow), mucosubstance (blue-green), red blood cells (red). Space between black
arrows indicates the thickness of the neointima. Yellow arrows indicate normal external and internal elastica. Objective magni-
fication x 20.
A B
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Investigation of the role of cytokines and growth factors
Growth factors possibly responsible for the neointimal
proliferation were studied based on their putative impor-
tance in autoimmune vasculopathies in humans. Immu-
nohistochemical analysis indicated a significant
overproduction of TGF-β 1, PDGF-A, and PDGF-B in the
MCMV induced intimal lesion (Fig. 5). While TGF-β  1
and PDGF-A immunoreactivity in affected arteries is lo-
calized to all three layers (intima, media, adventitia)
(Fig. 5B and 5D), PDGF-B staining is localized to the me-
dia and neointima (Fig. 5F). MCP-1, a chemokine that
has been implicated in pathogenesis of several autoim-
mune vascular diseases including SSc, was noted in the
adventitia and media of affected arteries (Fig. 6). We did
not detect MCP-1 positive staining in neointima (data
not shown).
Role of apoptosis and proliferation
Further, we investigated the role of apoptosis and prolif-
eration in vascular pathology triggered by MCMV infec-
tion of immunosuppressed mice. In situ TUNEL revealed
positive staining in the intimal layer of affected aortas
(Fig 7A). In addition, a small portion of infiltrating in-
flammatory cells stained positive by TUNEL (Fig. 7B).
Smooth muscle/myofibroblast cells forming the neointi-
ma did not reveal any cells positive by TUNEL (Fig. 7A).
Immunohistochemical staining for PCNA was used to
identify cell proliferation. The majority of cells in the ne-
ointima (Fig. 7C and Fig. 8), as well as infiltrating inflam-
matory cells (Fig. 7D and FIG. 8), exhibit
immunoreactivity for PCNA, indicating active prolifera-
tion.
Discussion
The major finding of this study is the formation of ne-
ointima associated with MCMV infection in immuno-
compromised mice. The disease described in our study
resembles pathological processes seen in other autoim-
mune vasculopathies. However, it is important to note
that while there are undoubtedly autoimmune aspects of
atherosclerosis, this issue is still under debate [17]. The
formation of neointima characteristic of the vasculopa-
thy in autoimmune diseases by this approach has, to our
knowledge, not been previously reported. While MCMV
vasculitis in IFN-γ R-/- mice has been previously report-
ed [18], that study does not focus on intimal prolifera-
tion. In our experimental conditions we were able to
increase yield from 62% affected animals in IFN-γ R-/-
mice infected with MCMV to 100% by including whole
body irradiation of chronically infected IFN-γ R-/- mice
(Table 1). In addition, a striking increase in the severity
of intimal lesions was noted in irradiated mice (Table 2).
We propose that there are two possible explanations for
the increase in both the number of affected animals, as
Figure 3
Immunohistochemistry of neointima.  A. Negative control for α -SMA staining (primary antibody omitted). B. Section of
the aorta collected from MCMV infected IFN-γ R-/- mouse 4 months after infection and 2 months after whole body irradiation
were stained with monoclonal anti α -SMA. Objective magnification x 40
B ABMC Musculoskeletal Disorders (2001) 2:3 http://www.biomedcentral.com/1471-2474/2/3
well as increase in the severity of vascular disease in
MCMV infected IFN-γ R-/- mice receiving whole body ir-
radiation treatment. First, sublethal irradiation addi-
tionally immunosuppresses the animals allowing
unlimited replication of MCMV which may lead to direct
viral damage. Second, the immune system after recover-
ing from effects of radiation (reconstitution) contains
large number of MCMV specific CTLs that may be capa-
ble of inducing intimal pathology while attempting to
clear the infection.
CMV infections have been implicated in a number of vas-
cular diseases. CMV invades the vascular endothelium
with the development of both latency and intermittent
shedding of the virus to distal tissues, often by detach-
ment of infected endothelial cells. In immunocompetent
individuals CMV infections are of chronic or latent type
and are usually not associated with clinically detectable
disease. In immunocompromised patients such as ne-
onates, transplant recipients and patients with AIDS,
CMV infections are a leading cause of organ failure and
death. Nonetheless, the mechanisms of CMV reactiva-
tion and induction of vascular lesions are not well under-
stood. Clinical and epidemiological studies strongly
suggest the association of CMV infection in the progres-
sion of numerous vascular diseases, including athero-
sclerosis [16–20], rapidly progressive coronary artery
disease, endothelialitis in heart transplant recipients
[21–24], coronary restenosis [25,26], and inflammatory
aortic disease [27,28] as well as SSc [11,12]. We attempt-
ed to reproduce the endpoint of such diseases by using
immunosupression and CMV infection, allowing us to
investigate cellular and molecular events leading to this
pathology. While SSc is an autoimmune disease affecting
Figure 4
Characterization of inflammatory infiltrate. Aortas collected from MCMV infected IFN-γ R-/- mice 4 months after infec-
tion and 2 months after whole body irradiation. A. Immunostaining specific for B-lymphocytes (B220+). B. Staining specific for
helper T-lymphocytes (CD4+). C. Staining specific for cytotoxic T-lymphocytes (CD8+). D. Immunostaining specific for γ /δ  T-
cell receptor bearing T-lymphocytes (γ /δ -TCR+). Objective magnification x 40
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Figure 5
Investigation of the role of growth factors in the pathogenesis of MCMV induced neointima formation.  A,C,E
abdominal aortas collected from control uninfected IFN-γ R-/- mice 2 months after whole body irradiation. B,D,F aortas col-
lected from MCMV infected IFN-γ R-/- mice 4 months after infection and 2 months after whole body irradiation.A&B staining
specific for TGF-β 1. C & D staining specific for PDGF-A. E & F staining specific for PDGF-B. Objective magnification x 40
AB
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microvasculature, some recent studies also described in-
creased incidence of vascular pathology in the large arte-
rial vessels of SSc patients [29–31]. However, it is still
unclear if macro vascular pathology is a primary feature
of SSc or an indirect effect of some of the downstream
events related to this disease.
Inoculation of immunocompetent mice with MCMV
causes persistent productive infection in salivary glands
followed by latency [32,33]. This latency is characterized
by the presence of the viral genome whereas infectious
viral particles could not be detected. In addition it was
possible to reactivate virus either in vivo or in vitro from
tissue explants. While there are several lines of evidence
to suggest that the immune system, or its absence, plays
a role in MCMV reactivation from latency [34,35] the
mechanism is not known. Latent CMV in many organs
can be reactivated from its dormant state by several
means of immunosuppression, including transmission
from donors to immunosuppressed recipients of trans-
plants, and blood transfusion.
Prior studies describe development of MCMV associated
vascular lesions in large arterial vessels of mice. The i.p.
injection of suckling mice induces vascular lesions in the
aorta and pulmonary artery, which are characterized by
cellular infiltrates containing T-lymphocytes [36]. A
more recent study describes the development of MCMV
induced vascular lesions in the aorta of both immuno-
competent mice and those lacking IFN-γ  responsiveness
where IFN-γ  is determined to be a major antiviral factor
preventing the long term persistence of aortic vascular
lesions [18]. The present study focused on neointima for-
mation, which was seen only in immunocompromised
mice. Our results indicated presence of both CD4+ help-
er, and CD8+cytotoxic T-lymphocytes in the adventitia of
the affected arteries. Significant portion of these T-lym-
phocytes are γ /δ -TCR+ This subpopulation of lym-
phocytes has been identified as part of the pathogenesis
of autoimmune diseases. For example, it has been shown
that γ /δ -TCR+ lymphocytes from SSc patients recognize
and lyse endothelial cells at a significantly higher rate
then γ /δ  cells isolated from control subjects [16]. Also, a
recent study indicates that γ /δ -TCR+ bearing lym-
phocytes play an important role in immune response of
immunosuppressed transplant recipients to CMV infec-
tion [37]. NK cells, natural antibodies, and complement,
potentially important in controlling CMV infection,
await further study.
Growth factors TGF-β , and PDGF are contributing fac-
tors in vascular diseases. TGF-β  upregulates α -smooth
muscle actin gene transcription [38]. Since we identified
significant  α -smooth muscle actin expression in our
model and this coincided with the expression of TGF-β ,
it is possible that TGF-β  mediates α -smooth muscle actin
expression in our model. The elevated expression of
PDGF in our model is also significant since the expres-
Figure 6
Immunohistochemical investigation of the expression of MCP-1.  A. Negative control for MCP-1 (primary antibody
omitted). B. Section of the aorta collected from MCMV infected IFN-γ R-/- mouse 4 months after infection and 2 months after
whole body irradiation were stained with polyclonal antibody specific for MCP-1. Objective magnification x 40
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sion of these growth factors by endothelial cells can be
induced by direct immune cell – endothelial cell interac-
tion, promoting smooth muscle cell migration and pro-
liferation in atherosclerosis [39]. CMV, as well as other
viruses, induces expression of a number of cytokines and
growth factors in cells in vitro, including TGF-β , a profi-
brogenic cytokine [40,41]. MCP-1 is a member of the β -
chemokine (C-C) family [42] and this chemokine has
been implicated in pathogenesis of SSc [43]. Our results
(Fig. 6) indicate that this chemokine may play a role in
recruitment of inflammatory cells to CMV infected vas-
culature.
We investigated the role of apoptosis in pathogenesis of
MCMV induced intimal lesion since apoptosis of virally
infected cells is one of the mechanisms by which host
may limit the virus spread. The presence of apoptotic T-
lymphocytes has been reported to be a feature of MCMV
infection [44]. Apoptosis of vascular endothelium in-
duced by immune effectors has been described in both
SSc patient vessels as well as those of UCD chickens (one
of the animal models for SSc) [45]. Recently, it has been
reported that IgG autoantibodies from SSc patients bind
CMV late protein UL94 and this induces apoptosis in hu-
man endothelial cells [15]. We detected the presence of
apoptotic cells in the intimal layer as well as in inflam-
matory infiltrate of the affected aortas (Fig. 7A & 7B). In
the future we will ask if apoptosis in our model is induced
by anti-endothelial autoantibodies, MCMV infection of
endothelium, or is induced and/or perpetuated by in-
Figure 7
Investigation of apoptosis and proliferation in the pathogenesis of MCMV induced neointima formation.  A and
B. TUNEL performed on the aorta collected from MCMV infected IFN-γ R-/- mouse 4 months after infection and 2 months
after whole body irradiation. C. and D. Immunostaining specific for PCNA. A. C. Neointima.B. D. inflammatory infiltrate.
Objective magnification x 40
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flammatory cells. Apoptosis of vascular endothelium
may be the trigger that initiates the uncontrolled repair
mechanism characterized by the proliferation of smooth
muscle cells/myofibroblasts, leading to the development
of neointima in MCMV induced vascular disease.
The development of CMV induced vasculopathies is a
major cause of morbidity and mortality in immunosup-
pressed patients. CMV infections have been identified as
important mediator of organ failure and death in trans-
plant recipients and AIDS patients. Although the role of
CMV infection in pathogenesis of vascular diseases in
immunocompetent patients is less clear, epidemiological
studies strongly suggest that chronic or latent infections
may accelerate the development of diseases such as
atherosclerosis and SSc. In fact, it is fair to hypothesize
that several diseases thought to be of "idiopathic" origin
may be triggered by chronic infections with CMV and
other infectious agents in the genetically susceptible
host. Animal models, such as those described in this pa-
per, will allow us to better understand the role that viral
infections play in the pathogenesis of vascular diseases.
It is crucial to identify factors responsible for contribut-
ing to the development of vascular pathology in order to
develop better preventive as well as treatment modali-
ties.
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